J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:January 25, 2018 Post category:BioPharma Now insiders say J&J has decided it is no longer interested. Source: BioSpace You Might Also Like STAAR Surgical Reports Fourth Quarter 2016 Results March 2, 2017 Kitov Pharma Surges as Lead Drug Hits Goals in Phase III Test October 26, 2017 Apricus Biosciences Announces Corporate Update And First Quarter 2017 Financial Results Conference Call May 3, 2017
Apricus Biosciences Announces Corporate Update And First Quarter 2017 Financial Results Conference Call May 3, 2017